Haemoglobin, ANC, and albumin levels are the risk factors for first cycle CIN, while pre-treatment ANC levels and anthracycline-taxane chemotherapy regimen are associated with CIN in any given cycle. The gene discussed is ALB; the disease is cervical squamous intraepithelial neoplasia.